Effect of antimalarial agents on the fasting lipid profile in systemic lupus erythematosus

Journal of Rheumatology

Volumn 27, Issue 9, 2000, Pages 2142-2145

  Lai Shan Tam, ^a   Gladman, D D ^a   Hallett, D C ^a   Rahman, P ^a   Urowitz, M B ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Antimalarial agents; Fasting lipids; Systemic lupus erythematosus

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYCHLOROQUINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PREDNISONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; CONTROLLED STUDY; DIET RESTRICTION; DISEASE COURSE; DRUG EFFECT; DYSLIPIDEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ANTIMALARIALS; FASTING; FEMALE; HUMANS; HYPERLIPIDEMIAS; LIPIDS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PREDNISONE;

EID: 0033816670     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years
2. The bimodal mortality pattern of systemic lupus erythematosus
3. Age specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham Study
4. Risk factors for coronary artery disease in patients with systemic lupus erythematosus
5. The natural history of hypercholesterolemia in SLE
6. Hydroxychloroquine use in the Baltimore Lupus Cohort: Effects on lipids, glucose and thrombosis
7. The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs
8. The lipid, lipoprotein, and apolipoprotein effects of hydroxychloroquine in patients with systemic lupus erythematosus
9. Hydroxychloroquine effects on lipoprotein profiles (the HELP trial): A double-blind, randomized, placebo-controlled, pilot study in patients with systemic lupus erythematosus
10. Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: Reversal of deleterious effects of steroids on lipids
11. Inhibition by chloroquine of the secretion of very low density lipoproteins by cultured rat hepatocytes
12. Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: A longitudinal data analysis
13. Prednisone increases very low density lipoprotein and high density lipoprotein in healthy men
14. Recombinant gamma-interferon induces hypertriglyceridemia and inhibits post-heparin lipase activity in cancer patients
15. Recombinant interleukin-1 suppresses lipoprotein lipase activity in 3T3-L1 cells
16. Dyslipoproteinemia in pediatric systemic lupus erythematosus
17. Origin and pattern of glucocorticoid-induced hyperlipidemia in rats. Dose-dependent bimodal changes in serum lipids and lipoproteins in relation to hepatic lipogenesis and tissue lipoprotein lipase activity
18. Glucocorticoids and triglyceride transport: Effects on triglyceride secretion rates, lipoprotein lipase, and plasma lipoproteins in the rat
19. Chloroquine inhibits cyclization of squalene oxide to lanosterol in mammalian cells
20. Inhibition of proteolytic degradation of low density lipoprotein in human fibroblasts by chloroquine, concanavalin A, and Triton WR 1339
21. Effects of chloroquine on the dyslipidemia of non-insulin-dependent diabetes mellitus
22. Plasma-triglycerides in regulation of HDL-cholesterol levels
23. Influence of plasma triglycerides on lipoprotein patterns in normal subjects and in patients with coronary artery disease
24. Crossreaction between antibodies to oxidised low-density lipoprotein and to cardiolipin in systemic lupus erythematosus